English Polski
Vol 6, No 3 (2013)
Review paper
Published online: 2013-10-11

open access

Page views 495
Article views/downloads 2575
Get Citation

Connect on Social Media

Connect on Social Media

Therapeutic Apheresis presented during the 23rd Regional Congress of the International Society of Blood Transfusion in Amsterdam

Aleksandra Rosiek
Journal of Transfusion Medicine 2013;6(3):112-117.

Abstract

Not available

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Garcia Gala JM, Martinez Reuelta E, Solano Tovar J, et al. Plasma exchange: a hospital register. Vox Sang. 2013; 105(supl. 1): 258.
  2. Szczepiorkowski Z, Winters J, Bandarenko N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the apheresis applications committee of the American Society for Apheresis. Journal of Clinical Apheresis. 2010; 25(3): 83–177.
  3. Chung YS, Lee KH, Kim MJ, et al. Pretransplant monitoring of plasmapheresis effects for donor specific anti-HLA antibody in a kidney tranplant recipient. Vox Sang. 2013; 105(supl. 1): 257.
  4. Pagacova L, Hoskova L, Kubanek M, et al. Immunoadsorption onto staphyloccocal protein A has a use for transplantology. Vox Sang. 2013; 105(supl. 1): 257–258.
  5. Mottola M, Bruno C, Giaquinto A, et al. Role of TPE in the ‘cardiac allograft rejection’: case report. Vox Sang. 2013; 105(supl. 1): 258.
  6. Engelbrecht S, Sloane J, McQuilten Z, et al. Management, complications of therapy and outcomes of TTP in Australia: data from the national registry. Vox Sang. 2013; 105(supl. 1): 255.
  7. Adraktas T, Kanellopoulou G, Marinaki A, et al. A long-term remission in patients with relapsing or refractory T.T.P. after Rituximab treatment. Vox Sang. 2013; 105(supl. 1): 255.
  8. Srejic V, Bogdanovic G, Milutinovic S, et al. Therapeutic plasma exchange in neurological patients treated from January to December 2012. Vox Sang. 2013; 105(supl. 1): 258.
  9. Bhatnagar NM, Gajjar MD, Shah SD, et al. Efficacy and cost effectiveness of therapeutic plasma exchange (TPE) in cases of Guillain-Barré syndrome (GBS). Vox Sang. 2013; 105(supl. 1): 256.
  10. Balint B, Todorovic-Balint M, Ostojic G, et al. Immediate benefit from plasma exchange in the treatment of severe hypertriglyceridemia using Spectra-Optia vs Cobe-Spectra. Vox Sang. 2013; 105(supl. 1): 256.
  11. Deshpande AS, Kalgutkar S, Sawant R. Therapeutic red cell exchange in malaria and sickle cell disease. Vox Sang. 2013; 105(supl. 1): 259.
  12. Lukic M, Bojanic I, Mazic S, et al. Our experience in treating hereditary hemochromatosis: erythrocytapheresis vs phlebotomy. Vox Sang. 2013; 105(supl. 1): 259.
  13. Vrielink H. Certifcation of apheresis nurses: development of an effective training program. Vox Sang. 2013; 105(supl. 1): 256.
  14. El Ekiaby M, Burnouf T, Radosevic M, et al. Safety and efficacy of mini-pool S/D cryoprecipitate-poor-plasma (S/D-CPP) in partial volume therapeutic plasma exchange. Vox Sang. 2013; 105(supl. 1): 257.
  15. Rosiek A. Hemafereza lecznicza i inne wybrane zagadnienia (w świetle doniesień prezentowanych na 21. Regionalnym Zjeżdzie Międzynarodowego Towarzystwa Przetaczania Krwi [ISBT] w Lizbonie 18–22 czerwca 2011 roku). J Transf Med. 2012; 5(3): 140–145.
  16. Abstracts of the 22nd Regional Congress of the ISBT (International Society of Blood Transfusion) Asia. Vox Sang. 2011; 101 (supl. 2): 117–118 Taipei, 19-23.2011.